Evasion of Type I Interferon by SARS-CoV-2
The University of Texas Medical Branch at Galveston · Jilin University
Abstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication and host immune response determine coronavirus disease 2019 (COVID-19), but studies evaluating viral evasion of immune response are lacking. Here, we use unbiased screening to identify SARS-CoV-2 proteins that antagonize type I interferon (IFN-I) response. We found three proteins that antagonize IFN-I production via distinct mechanisms: nonstructural protein 6 (nsp6) binds TANK binding kinase 1 (TBK1) to suppress interferon regulatory factor 3 (IRF3) phosphorylation, nsp13 binds and blocks TBK1 phosphorylation, and open reading frame 6 (ORF6) binds importin Karyopherin α 2 (KPNA2) to inhibit IRF3 nuclear translocation. We identify two…
Citation impact
- FWCI
- 65.22
- Percentile
- 100%
- References
- 58
Authors
9- HXHongjie XiaCorresponding
The University of Texas Medical Branch at Galveston
- ZCZengguo Cao
Jilin University, The University of Texas Medical Branch at Galveston
- XXXuping Xie
The University of Texas Medical Branch at Galveston
- XZXianwen Zhang
The University of Texas Medical Branch at Galveston
- JYJohn Yun-Chung Chen
The University of Texas Medical Branch at Galveston
Topics & keywords
- STAT1
- Biology
- IRF3
- Interferon
- STAT2
- Interferon regulatory factors
- Virology
- Coronavirus
- Good health and well-being
Funding
- AGAmon G. Carter Foundation
- AKAlice Kleberg Reynolds Foundation
- JSJohn S. Dunn Foundation
- UOUniversity of Texas System
- GLGillson Longenbaugh Foundation
- RJRobert J. Kleberg, Jr. and Helen C. Kleberg Foundation
- SGSummerfield G. Roberts FoundationAwards: R01AI134907, U19AI100625, R24AI120942, R00AG049092, R21AI132479-01, R21AI126012-01A1
- SASealy and Smith Foundation
- NINational Institutes of HealthAwards: AI134907, AI142759, AI145617, UL1TR001439